Emerging Companies

Overview

Our Emerging Companies team understands the entrepreneurs’ journey and provides tailored legal services to help bring their visions to life.

We help innovators who are laser-focused on optimizing business and legal decisions at high velocity. We offer guidance on business planning, organizational structure, and investor presentations, as well as the full-service corporate capabilities that maturing businesses need. Our attorneys negotiate, structure, and close venture capital funding deals and all types of strategic alliances and joint ventures. We leverage our relationships with a broad network of investors to negotiate optimal terms and conditions.

We also serve as outside general counsel for companies, both large and small, advising on a broad range of business issues. Trust us to navigate the complexities of startup laws and provide unwavering support for your emerging business.

Representative experience

• Yasso, Inc.: Represented the creator of the first-ever frozen Greek yogurt bars in connection with its growth equity financings and its transaction with Castanea Partners
• Grillo’s: Represented a gourmet pickle company through rounds of growth equity financings and, eventually, in its sale to King’s Hawaiian
• MC10, Inc.: Represented a digital health company in the sale of its digital biomarker business, which creates wearable sensors to facilitate virtual clinical trials
• Doing Things Media, Inc.: Represented a leading media company in its Series A Preferred Stock Financing
• ConnectIQ Labs, Inc. (dba Miles): Represented a universal miles rewards program in its Series A Preferred Stock Financing
• Circle Medical Technologies, Inc.: Represented a San Francisco-based adult primary care and telehealth services provider in its Series A Preferred Stock financing and private tender offer from WELL Health Technologies Corp.
• Codagenix: Represented a clinical-stage biotechnology company leading a new era of live vaccines and viral therapeutics in its Series B Preferred Stock financing led by Adjuvent Global Health and the Topspin Fund

Recognition

• Nixon Peabody has been named a Tier 1 National firm for Securities/Capital Markets Law and Securities Regulation in the 2024 edition of Best Law Firms®.
• Ranked in Chambers USA for Startups & Emerging Companies in 2023 and 2022
• Named as a leading firm in Corporate/M&A by Chambers in 2022
• Over half of our corporate partners and counsel recognized by Chambers, Legal 500, and The Best Lawyers in America© 2022–2023 as leading attorneys in the field
• Named one of the 32 most trusted firms for M&A according to the “2022 Dauntless Dealmakers” report by BTI Consulting Group
• Awarded Deal of the Year for multiple transactions in recent years by various sources, including The Deal, the Association for Corporate Growth, and the M&A Advisor
• Recognized as a leader in middle-market mergers, acquisitions, and buyouts by Legal 500 in 2022